Tacrolimus and the enzyme CYP3A5
Tacrolimus is processed to a large extent by the enzyme CYP3A5. The activity of this enzyme can vary considerably depending on your genetic predisposition, which means the efficacy of tacrolimus can also differ from person to person.
Information about your genetic predisposition may therefore provide grounds for extra vigilance in relation to a treatment with tacrolimus.
Read more about CYP3A5 enzyme »